# Netupitant + Palonosetron

## Akynzeo 300/0.5mg

| 藥物代碼           | OAKY                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Chemotherapy-induced nausea and vomiting, Acute and delayed; Prophylaxis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 副作用             | CommonDermatologic: Erythema (3% )Gastrointestinal: Constipation (3% ), Indigestion (4% )Musculoskeletal: Asthenia (8% )Neurologic: Headache (9% )Other: Fatigue (4% to 7% )SeriousOther: Serotonin syndrome                                                                                                                                                                                                                                                                                                                                                                               |
| 禁忌               | Specific contraindications have not been determined.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 藥物保存方式       | 攝氏25度C以下                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 用法用量           | Highly emetogenic chemotherapy (including cisplatin-based regimens): Administer netupitant 300 mg/palonosetron 0.5 mg (1 capsule) orally 1 hour prior to chemotherapy on day 1; coadminister dexamethasone 12 mg orally 30 minutes prior to chemotherapy on day 1, and 8 mg orally on days 2 to 4. Anthracycline and cyclophosphamide-based regimens and other regimens not highly emetogenic: Administer netupitant 300 mg/palonosetron 0.5 mg (1 capsule) orally 1 hour prior to chemotherapy on day 1; coadminister dexamethasone 12 mg orally 30 minutes before chemotherapy on day 1. |
| 肝功能異常         | 需 調 整 劑 量  Hepatic impairment, severe (Child-Pugh score greater than 9): Avoid use [Micromedex 20201007]                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 腎功能異常         | 需 調 整 劑 量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 附帶說明           | Netupitant: 沒有資料 Palonosetron: No Human Data - Animal Data Suggest Low Risk [仿單]上未針對懷孕女性進行充分且對照良好的Akynzeo研究...略...給與母鼠最高至相當於3.7倍 人體建議劑量AUC的netupitant劑量時,幼鼠並未觀察到不良反應的發生.在palonosteron的動物生殖 研究中,於胎兒的器官生成階段分別給予大鼠及大白兔口服相當於達人體口服建議劑量921與 1841倍藥物時,未觀察到影響胚胎-胎兒的發育.Akynzeo應在潛在利益高於胎兒潛在風險時,方可 於懷孕期間使用.                                                                                                                                        |
| 哺乳期用藥建議     | Unknown 尚未建立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 附帶說明           | Netupitant: 沒有資料 Palonosetron: No Human Data - Probably Compatible [仿單]目前尚未知Akynzeo是否會進入人體乳汁中.由於許多藥物會進入人體乳汁中,且palonosteron 在大鼠致癌性研究中顯示有潛在致腫瘤性,故應考量藥物對於母親的的重要性來決定是否停止 哺乳或停藥.                                                                                                                                                                                                                                                                                                                               |
| 注射劑給藥建議途徑 | AC, AC15, PC, PO, WM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 注意事項           | 本藥膠囊中含有三片藥錠及一粒膠囊,若病患有需求可以拆開後依序吞服.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

